Health-e Law Episode 26, Part 2 | AI Adoption in Healthcare: Opportunities, Risks and the Future of Care Delivery
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 278: Equipping Health Systems with the Right AI Solutions with Dr. Mark Sendak of Vega Health
Episode 420 -- DOJ Announces New West Coast Health Care Fraud Strike Force
Hospice Insights Podcast - Bottom Line, Top of Mind: Compliance Checklists for Hospice and Home Health
Health-e Law Podcast, Episode 26 Pt. 1 | AI Adoption in Healthcare: Managing Data Privacy, Vendor Relationships and Governance
False Claims Act Insights - Managed Care FCA Enforcement: Risk Adjustment, AI, Kickbacks, and More
Podcast — Drug Pricing and Market Access: CMS Update With Rujul Desai
Podcast — Drug Pricing and Market Access: Highlights From Recent CMS and AHLA Conferences
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 277: M&A Trends and Growth in the Life Sciences Industry with John Erwin of Maynard Nexsen
Patients Recording Medical Visits: What Health Care Providers Need to Know
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 276: Educating the Life Sciences Workforce with Wake Tech’s Leslie Isenhour
Podcast - The New Rules of Healthcare Fraud Enforcement
Hospice Insights Podcast - Hospice Audit Updates: UPICs May Pick You for a Prepayment Review
Strategic Alignment With Collaboration Is Essential to a Life Sciences M&A Exit — Troutman Pepper Locke Podcast
AI's Hidden Power Grid: Data Centers, Subsea Cables, and the New Infrastructure Arms Race — The Good Bot: Artificial Intelligence, Health Care, and the Law
Charting a Course for Collections: Diagnosing Compliance and Privacy Risks in Medical Debt — The Consumer Finance Podcast
Taking The Pulse, A Health Care and Life Sciences Video Podcast | Episode 275: Strategies for Building the Life Sciences Talent Pipeline with NIIMBL’s John Balchunas
Health+Tech - Healthcare Private Equity Conference Recap
Health+Tech - From Software to Scrutiny: Navigating FDA Inspections Under the New QMSR
Health+Tech - The Perfect Storm: Cyber Threats, Regulation and AI in Healthcare
News Briefs - Hospitals Seek Exemptions from Planned Merger Requirements As the federal government readies its second crack at overhauling the information dealmakers must submit to regulators ahead of a planned merger, the...more
On June 9, 2026, the full House Appropriations Committee met to consider and advance the FY 2027 Labor-HHS appropriations bill. The bill provides $110.8 billion to the US Department of Health and Human Services (HHS) for FY...more
AI adoption in healthcare is no longer limited to large health systems and well-capitalized technology platforms. With 46% of healthcare organizations currently implementing generative AI technologies, the question is no...more
Trending in Telehealth highlights monthly state legislative and regulatory developments that impact the healthcare providers, telehealth and digital health companies, pharmacists, and technology companies that deliver and...more
Former Congressman Peter Roskam, who leads BakerHostetler’s Federal Policy team, provides listeners with a front-row seat to the most important policy and political debates in Congress. In this episode of “The Cloakroom with...more
This Legislative Session Summary provides a comprehensive recap of the major issues, legislation, and policy developments addressed during the 2026 legislative session. To make navigation easier, content has been organized by...more
To help you stay on top of the latest news, our AI practice group has compiled a roundup of the developments we are following....more
Highlight of the Week - This week, the House Appropriations Committee passed the Fiscal Year (FY) 2027 Labor-HHS appropriations bill on a 34-28 party line vote and CMS issued guidance on its plans to strengthen budget...more
Health care industries are facing increasing environmental regulatory pressure, particularly regarding packaging, PFAS restrictions, and carbon footprint requirements, which has direct implications for market access and...more
In the June edition of For Your Consumption, our food & beverage digest of court cases and litigation trends affecting the food, beverage, agribusiness, and cosmetics industries, corn is dressed up as apples, salsa is spicier...more
On May 22, 2026, the Centers for Medicare & Medicaid Services (“CMS”) published a proposed rule (the “Proposed Rule”) that would implement, and in several respects expand beyond, the Medicaid state directed payment (“SDP”)...more
So, I had some free time today and decided to work with AI on an assessment of comments submitted to FDA’s November 2023 Proposed Rule (the “proposed rule”) to classify antimicrobial wound dressings and washes....more
The U.S. Department of Labor issued a new FLSA opinion letter on May 28, 2026, addressing a practical staffing question for hospitals and other employers: Can an exempt employee perform additional hourly, non-exempt work for...more
Summary - For the first time, the U.S. Environmental Protection Agency (EPA) has formally designated pharmaceuticals as a priority drinking water contaminant group under the draft Sixth Contaminant Candidate List (CCL 6)....more
Over the past year, there have been some impressive medical malpractice verdicts throughout the country. Juries remain willing to recognize that patients and their families have suffered significant harm due to healthcare...more
Our Drug Pricing and Market Access team tracks recent developments in healthcare reform, the Medicaid Drug Rebate Program, the 340B Program, Medicare, and state law....more
As health care leaders from across Michigan prepare to gather on Mackinac Island later this month, there is no shortage of issues competing for their attention. Reimbursement pressures continue to challenge financial...more
On June 5, Lupin announced that the U.S. Food and Drug Administration (“FDA”) approved RANLUSPEC, a ranibizumab biosimilar to Genentech’s LUCENTIS®. ...more
Here are curated AG and federal regulatory news stories highlighting key areas in which state and federal regulators’ decisions are having an impact across the US: • AG James Multistate Coalition Secures $36.5 Million...more
On June 3, 2026, CMS published an interim final rule with comment period (the “Rule”) implementing a new Medicaid work and community engagement requirement. This Rule carries out a provision in the One Big Beautiful Bill Act...more
In a unanimous decision of June 4, 2026 in Hikma Pharmaceutical USA Inc. v. Amarin Pharma Inc., authored by Justice Jackson, the Supreme Court clarified the pleading requirements for claims of induced patent...more
In the recent ruling in Hikma Pharmaceuticals v. Amarin Pharma, No. 24–889., the U.S. Supreme Court applied its pleading standards established in the Twombly and Iqbal line of cases and unanimously held plaintiff, Amarin...more
On May 27, 2026, Assistant Attorney General Brett A. Shumate issued a memorandum to attorneys in the Commercial Litigation Branch’s Fraud Section and to Assistant United States Attorneys handling FCA cases that may materially...more
The U.S. Departments of Health and Human Services, Labor, and Treasury (the "Departments") and the Office of Personnel Management released a Final Rule on May 28, 2026, significantly restructuring the Federal Independent...more
The Department of Justice (DOJ) is sharply accelerating its review of benefits-fraud qui tam cases. Our White Collar, Government & Internal Investigations and Health Care teams investigate how a new memorandum signals faster...more